Seegene, Eisai sales and marketing update

Seegene granted Eisai's in vitro diagnostic subsidiary, Eidia Co. Ltd., exclusive rights to market Seegene's TOCE technology-based multiplexed molecular diagnostic tests in Japan. Eidia will be respon...